| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 03/13/2002 | EP0937068B1 Process for the crystallization of losartan |
| 03/13/2002 | EP0901473B1 Piperazinylalkylthiopyrimidine derivatives, pharmaceutical compositions containing the same and a process for the preparation of the novel compounds |
| 03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
| 03/13/2002 | CN1340058A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 03/13/2002 | CN1339720A Photographic composition containing ditriazinyl sub-aryl diamine derivatives |
| 03/12/2002 | US6355809 Method for preparing (2s)-1-(2r3s)-5-chloro-3-(2-chlorophenyl) -1-(3,4-dimethoxy benzene-sulphonyl) 3-hydroxy-2,3-dihydro-1h-indole-2-carbonyl pyrrolidine-2-carboxamide |
| 03/12/2002 | US6355808 Benzimidazole compounds, their production and use |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355695 Antihistamines; asthma therapy |
| 03/12/2002 | US6355664 Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/12/2002 | US6355642 Tetrahydrobenzindole compounds |
| 03/12/2002 | US6355631 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
| 03/12/2002 | US6355460 Detecting enzyme inhibitors; incubate enzyme with modulator, monitor sample for reduction in enzyme activity, reduction in enzyme activity indicates modulator |
| 03/07/2002 | WO2002018432A2 Protein extracted from the intestines of vertebrates, which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | WO2002018370A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof |
| 03/07/2002 | WO2002018349A2 Process and intermediates for preparing retroviral protease inhibitors |
| 03/07/2002 | WO2002018346A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | WO2002018339A2 Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 03/07/2002 | WO2002017924A1 Method of treatment |
| 03/07/2002 | WO2001090103A9 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 03/07/2002 | WO2001089457A3 Thrombopoietin mimetics |
| 03/07/2002 | WO2001068047A3 Preparation containing quinoxaline derivatives |
| 03/07/2002 | WO2001062765A3 Small molecule modulators of g protein-coupled receptor six |
| 03/07/2002 | WO2001057022A3 Pyrazole compositions useful as inhibitors of erk |
| 03/07/2002 | WO2001055131A3 Prodigiosin-derivatives as neoplastic and anti-viral agents |
| 03/07/2002 | WO2001023377A3 Polymorphic salt |
| 03/07/2002 | US20020028840 2-indolinone derivatives as modulators of protein kinase activity |
| 03/07/2002 | US20020028838 E.g., 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7 hexahydro-pyrazolo-(4,3-c)pyridin-5-yl)-1-(R)-benzyloxymethyl- 2-oxo-ethyl)-isobutyramide; mobility impairments, e.g. identified by balance and gait, in the elderly |
| 03/07/2002 | US20020028835 Cyclic amine phenyl beta-3 adrenergic receptor agonists |
| 03/07/2002 | US20020028828 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 03/07/2002 | US20020028810 Substituted N-( indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors |
| 03/07/2002 | US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors |
| 03/07/2002 | US20020028803 Controlling cell apoptosis |
| 03/07/2002 | DE10042061A1 Bicyclische Heterocyclen,diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | CA2731273A1 Processes and intermediates for preparing retroviral protease inhibitors |
| 03/07/2002 | CA2420652A1 Vertebrate intestinal protein which absorbs cholesterol, and the use of this protein for identifying inhibitors of intestinal cholesterol transport |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/07/2002 | CA2417042A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 03/06/2002 | EP1184373A1 Tricyclic compounds |
| 03/06/2002 | EP1184035A2 Use of growth hormone secretagogues for treatment of physical performance decline |
| 03/06/2002 | EP1183262A1 Intermediates for and synthesis of 3-methylene cephams |
| 03/06/2002 | EP1183252A1 New pharmaceutically active compounds |
| 03/06/2002 | EP1183245A1 Selective npy (y5) antagonists |
| 03/06/2002 | EP1183243A1 Short-acting benzodiazepines |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP0994865B1 Triazole compounds and the use thereof as dopamine-d 3-ligands |
| 03/06/2002 | EP0728748B1 Benzodiazepine derivatives |
| 03/06/2002 | EP0695295B1 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation |
| 03/06/2002 | CN1339025A Indole derivatives and their use as MCP-1 antagonists |
| 03/06/2002 | CN1338938A Use of moxonidine for postmyocardial infarction treatment |
| 03/06/2002 | CN1338456A Benzodiazapine compounds containing imidazole propanamido and its preparing process and application |
| 03/06/2002 | CN1080262C Novel substituted 4-(1H-benzimidazol-2-YL)[1,4] diazepanes useful for the treatment of allergic diseases |
| 03/06/2002 | CN1080261C 3-substituted 1-arylindole compounds |
| 03/06/2002 | CN1080260C Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 03/06/2002 | CN1080257C Guanidine derivatives |
| 03/05/2002 | US6353116 Endothelin receptor antagonists |
| 03/05/2002 | US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents |
| 03/05/2002 | US6352989 Nitrogenous heterocyclic derivatives and medicine thereof |
| 03/05/2002 | US6352985 Benzimidazole compounds |
| 03/05/2002 | US6352981 Treat disorders which respond to dopamine d.sub.3 ligands such as schistosomiasis, schizophrenia, depression, neuroses or psychoses |
| 03/05/2002 | US6352958 Pre- and post-emergence herbicides |
| 03/05/2002 | CA2272138C Pyrazolopyrimidine and pyrazolopyridine compounds having crf antagonist activity |
| 03/05/2002 | CA2266565C Azabicyclic rotomase inhibitors |
| 02/28/2002 | WO2002016362A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016361A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016360A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016351A1 Quinazoline derivatives as kinase inhibitors |
| 02/28/2002 | WO2002016327A1 Benzimidazoles and analogues and their use as neutrophil inhibitors |
| 02/28/2002 | WO2002016313A2 Integrin receptor inhibitors |
| 02/28/2002 | WO2002015909A1 Substituted piperidines as melanocortin receptor agonists |
| 02/28/2002 | WO2001087887A3 Neuroprotective and anti-proliferative compounds |
| 02/28/2002 | WO2001085699A3 Prodrugs of hiv replication inhibiting pyrimidines |
| 02/28/2002 | WO2001079167A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/28/2002 | WO2001077080A3 Pyrazole compounds having anti proliferative activity |
| 02/28/2002 | WO2001064639A3 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 02/28/2002 | WO2001060347A3 Method for treating ocular pain |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | US20020026059 Use as microbicides in crop protection |
| 02/28/2002 | US20020026056 Substituted imidazoles having cytokine inhibitory activity |
| 02/28/2002 | US20020025967 Antiserotinone agents |
| 02/28/2002 | US20020025963 Novel guanidine mimics as factor Xa inhibitors |
| 02/28/2002 | US20020025957 Anticoagulants, cardiovascular disorders |
| 02/28/2002 | US20020025948 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| 02/28/2002 | US20020025910 3-heterocycly1 - substituted benzoyl derivatives |
| 02/28/2002 | CA2419580A1 Integrin receptor inhibitors |
| 02/28/2002 | CA2419310A1 Substituted piperidines as melanocortin receptor agonists |
| 02/27/2002 | EP1182501A2 Photographic processing composition containing bistriazinyl arylenediamine derivative |
| 02/27/2002 | EP1181940A2 In vivo diagnostics by near infrared radiation |
| 02/27/2002 | EP1181287A1 Sulfonamide compounds with pharmaceutical activity |
| 02/27/2002 | EP1181269A1 Cell proliferation inhibitors |
| 02/27/2002 | EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 02/27/2002 | EP1152001A9 Squarylium compound and optical recording medium containing the same |
| 02/27/2002 | EP0892789B1 Irreversible inhibitors of tyrosine kinases |
| 02/27/2002 | EP0783495B1 Quinoxaline derivatives useful in therapy |
| 02/27/2002 | CN1337952A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors |
| 02/27/2002 | CN1337851A Converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors |
| 02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |
| 02/26/2002 | US6350880 Crystalline or crystallized acid addition salt of losartan and purification method of losartan |